Cargando…
Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen
Intravenous iloprost is a first-line option for the treatment of scleroderma-related digital vasculopathy, and some studies have suggested its favourable role on disease progression. The aim of our study is to evaluate the disease progression, specifically in terms of cardiopulmonary function, in a...
Autores principales: | Foti, Rosario, Visalli, Elisa, Amato, Giorgio, Benenati, Alessia, Converso, Giovanni, Farina, Alberto, Bellofiore, Salvatore, Mulè, Massimiliano, Di Gangi, Marcella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5258785/ https://www.ncbi.nlm.nih.gov/pubmed/27796521 http://dx.doi.org/10.1007/s00296-016-3582-4 |
Ejemplares similares
-
Clinical and Histopathological Features of Scleroderma-like Disorders: An Update
por: Foti, Rosario, et al.
Publicado: (2021) -
SARS-CoV-2 infection in a psoriatic arthritis patient treated with IL-17 inhibitor
por: Foti, Rosario, et al.
Publicado: (2020) -
Management of Patients With Inflammatory Rheumatic Diseases: Telemedicine and Rheumatologists Challenged in the Era of COVID-19
por: Foti, Rosario, et al.
Publicado: (2020) -
Sudden winter iloprost withdrawal in scleroderma patients during COVID-19 pandemic
por: De Lorenzis, Enrico, et al.
Publicado: (2022) -
Dry Eye in Systemic Sclerosis Patients: Novel Methods to Monitor Disease Activity
por: Gagliano, Caterina, et al.
Publicado: (2020)